• Send Us A Tip
  • Calling all Tech Writers
  • Advertise
Saturday, July 19, 2025
  • Login
TechStory
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to
No Result
View All Result
TechStory
No Result
View All Result
Home News

Pre-Series A undisclosed funding announced by Ahammune Biosciences

by Ayushi Mehta
April 26, 2021
in News, Startups
Reading Time: 2 mins read
0
vitiligo

man with vitiligo

TwitterWhatsappLinkedin
vitiligo
man with vitiligo

Ahammune Biosciences, a Pune based biotech startup company released an undisclosed amount of funds raised by Ideaspring Capital and Indian Angel Network. The funds were raised for the pre-series A.

You might also like

Viceroy Report Raises Concerns Over Vedanta Semiconductor Unit’s Dealings

India Emerges as Global iPhone Hub: Apple Exports Hit $5 Bn in Just One Quarter

ED Summons Google and Meta Over Alleged Promotion of Online Betting Apps

The raise funds will be put to use for first hand, ‘first-in-humans trials’ for the Ahammune’s new drug candidate AB1001 for vitiligo. This study which is to be conducted shall include Phase-I safety studies in healthy human volunteers and Phase-II efficacy studies in vitiligo patients. Apart from this, these funds are also going to be used in building the patent portfolio of the drug for further research and development and studies.

In this socially-conscious endeavor, Ahammune has received support from the government in the form of tax-exemption for 3 years on capital gains.

Ahammune Biosciences filled the first Investigational New Drug (IND) Application with the Drug Controller General of India (DCGI) for permission to conduct human trails for its newly designed drug for vitiligo.

The current treatments and trails for Vitiligo provide only temporary and symptomatic relief. Thus, there is an enormous unmet global need in treating patients with Vitiligo.

While talking about the latest development of the drug, Dr. Parul Ganju, Co-founder and CEO of Ahammune Biosciences said- “Currently, there is no cure for vitiligo. Our drug aims to fulfill the unmet need in Vitiligo therapeutic. We have positioned it as a topical solution, a segment of the market that accounted for 54% of the total market share of available options. Our preclinical data suggest our drug candidate is very safe and is able to stop the spread of depigmentation and re-pigment white patches in animal models. Based on these studies, the first intended use of the drug will be in patients with non-segmental vitiligo, who have active vitiligo.”

Vitiligo is a skin de-pigmentation and de-coloration disorder. It has affected around 1% to 2% of the entire world’s population. However the disorder is a huge deal in India with around 8% of the population being affected by it.

Apart from developing the drug for vitiligo, this biotech company is focusing on targeting various other dermatological indications with its deep pipeline of IP-based molecules that modulate cellular pathways underlying skin health and immunity.

Ahammune Biosciences was founded by Dr. Krishnamurthy Natarajan and Dr. ParuI Ganju, Ahammune Biosciences boasts of a highly experienced and skilled founding team. The team brings together both scientific discovery and development expertise in the dermatology arena. This company was started with the vision of creating drugs and coming up with cost effective ways to treat different chronic skin diseases and has been doing that almost successfully.

Tags: de-pigmentationhuman trailsskin discolorationskin disorderskin drugvitiligo
Tweet54SendShare15
Previous Post

Alphabet’s X moonshot division wants to bring AI to the electric grid

Next Post

upGrad, A Major Global Edtech Company Raises $120 Million.

Ayushi Mehta

Hey! My name is Ayushi Mehta, I'm 19 years old. I am a big time literature and tech enthusiast. A cub Journalist. Thank you for checking out my articles! To connect, email me at- [email protected]

Recommended For You

Viceroy Report Raises Concerns Over Vedanta Semiconductor Unit’s Dealings

by Rounak Majumdar
July 19, 2025
0
Viceroy Report Raises Concerns Over Vedanta Semiconductor Unit’s Dealings

A new report by US-based short seller Viceroy Research has brought the spotlight back onto Vedanta Limited’s semiconductor ambitions, raising serious questions about the business practices of its...

Read more

India Emerges as Global iPhone Hub: Apple Exports Hit $5 Bn in Just One Quarter

by Ishaan Negi
July 19, 2025
0
Apple to pay up to $500 million to iPhone users after judge nixes final appeal

India's ambition to become a global electronics powerhouse just got a significant boost. Apple has exported over $5 billion worth of iPhones from India during the April–June quarter...

Read more

ED Summons Google and Meta Over Alleged Promotion of Online Betting Apps

by Rounak Majumdar
July 19, 2025
0
ED Summons Google and Meta Over Alleged Promotion of Online Betting Apps

The Enforcement Directorate (ED) has escalated its action against illegal online betting platforms by issuing summons to top technology giants Google and Meta. This move forms a crucial...

Read more
Next Post
Founders of upGrad-

upGrad, A Major Global Edtech Company Raises $120 Million.

Please login to join discussion

Techstory

Tech and Business News from around the world. Follow along for latest in the world of Tech, AI, Crypto, EVs, Business Personalities and more.
reach us at [email protected]

Advertise With Us

Reach out at - [email protected]

BROWSE BY TAG

#Crypto #howto 2024 acquisition AI amazon Apple Artificial Intelligence bitcoin Business China cryptocurrency e-commerce electric vehicles Elon Musk Ethereum facebook funding Gaming Google India Instagram Investment ios iPhone IPO Market Markets Meta Microsoft News NFT samsung Social Media SpaceX startup startups tech technology Tesla TikTok trend trending twitter US

© 2024 Techstory.in

No Result
View All Result
  • News
  • Crypto
  • Gadgets
  • Memes
  • Gaming
  • Cars
  • AI
  • Startups
  • Markets
  • How to

© 2024 Techstory.in

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?